We asked 40 pharma leaders, 2012 has been touted as a crucial year of the so-called patent cliff. Do you think the impact of patent expiries has been better or worse than expected?
US Election: Pharma and Obamacare after November 6th No doubt today's US election is going to be close; so close, in fact, it's possible that no substantial political change will occur in Washington, as a result. That said, for the US pharmaceutical industry this is not going to be an election without consequence More...
Sciformix's Integrated Drug Safety solution seamlessly interweaves and synchronizes services across all phases of the product lifecycle. Our unitary approach to risk management provides your organization with updated safety profiles of your developmental and licensed products to assist in addressing emerging safety issues and regulatory requests in a comprehensive and timely manner. Read more
